Navigation Links
Reportlinker Adds 2010 Pharmaceuticals Research Review
Date:12/14/2010

A, 1983-2009 27

APPLICATIONS FOR ORPHAN DRUG DESIGNATIONS HAVE DOUBLED 28

PROFITABILITY OF ORPHAN DRUGS 28

Market Exclusivity 28

No Regulatory Restrictions on Pricing 29

Off-Label Use 29

CHALLENGES FOR EFFECTIVE USE OF THE ODA 30

MARKET EXCLUSIVITY VERSUS PATENT PROTECTION 30

MARKET SIZE AND KEY PLAYERS 31

TABLE 10 TOP 10 COMPANIES IN THE ORPHAN DRUG MARKET AND THEIR MARKET SHARES (%) 32

THE ORPHAN DRUG ACT — A BONUS FOR BIOTECH 32

BIG PHARMA IS ENTERING THE ORPHAN DRUGS SECTOR AGGRESSIVELY 32

CONCERNS ABOUT THE ORPHAN DRUG ACT 33

COST-EFFECTIVENESS 34

PRICING OF ORPHAN DRUGS 34

TABLE 11 SOME EXAMPLES OF HIGHLY EXPENSIVE ORPHAN DRUGS AND THEIR PRICES 35

High-Priced Orphan Drugs Leading to Price Control Measures by Governments 36

TABLE 12 SOME OF THE RECENT CONTROVERSIES RELATED TO ORPHAN DRUGS PRICING 37

ACCESS TO ORPHAN DRUGS AND REIMBURSEMENT — CURRENT PRACTICES 38

Orphan Drug Access and Reimbursement Scenario in the U.S. 38

Access and Reimbursement Scenario in Europe 38

TABLE 13 ORPHAN DRUG ACCESS AND REIMBURSEMENT PRACTICES  IN EUROPEAN COUNTRIES 39

TABLE 13 (CONTINUED) 40

TABLE 13 (CONTINUED) 41

Call for Unification of Orphan Drug Access Across Europe 41

INNOVATIVE APPROACHES OF PRICING AND REIMBURSEMENT 42

TABLE 14 EMERGING TRENDS IN PRICING AND REIMBURSEMENT OF HIGH-PRICED DRUGS 42

TABLE 14 (CONTINUED) 43

Chapter-4: DRUG-DEVICE COMBINATIONS: THE GLOBAL MARKET (PHM045B)

INTRODUCTION 44

STUDY GOALS AND OBJECTIVES 44

REASONS FOR DOING THIS STUDY AND ITS IMPORTANCE 44

INTENDED AUDIENCE 45

SCOPE OF REPORT 45

METHODOLOGY AND INFORMATION SOURCES 45

ANALYST CREDENTIALS 46

SUMMARY 46

SCOPE OF THE INDUSTRY 46

DRUG-DEVICE COMBINATIONS: THE GLOBAL MARKE
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... , Nov. 25, 2014  Array ... today announced that its Chief Executive Officer, ... the following upcoming conferences.  The public is ... webcasts on the Array BioPharma website:  ... 3, 2014Time:1:30 p.m.  Eastern Time Location: Palace ...
(Date:11/26/2014)... Calif. and LONDON , Nov. ... and AstraZeneca (NYSE: AZN ) today announced that ... two doses of brodalumab in more than 1,800 patients with ... both Stelara ® (ustekinumab) and placebo at week 12. ... weight-based analysis group were each shown to be superior to ...
(Date:11/26/2014)... YORK and HERZLIYA PITUACH, Israel, Nov. 25, ... "Immune" or "the Company"), a clinical stage biopharmaceutical ... of targeted therapeutics for the treatment of inflammatory ... its previously announced underwritten public offering of 3,450,000 ... of the Company,s common stock, par value $0.0001 ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... Corporation (OTCQX:RXPC) (OTCPK:RXPC), a developer and marketer of ... financial results for its third quarter ended September 30, ... September 30, 2011 were $102,238 as compared to $34,446 ... nine months ended September 30, 2011, revenues were $257,609, ...
... Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, ... Senior Vice President and Chief Medical Officer. ... experience in the medical field.  He comes most recently ... and Medical Director of Global Businesses since 2005. In ...
Cached Medicine Technology:Radient Pharmaceuticals Announces FY 2011 Third Quarter Results 2Radient Pharmaceuticals Announces FY 2011 Third Quarter Results 3Prometheus Announces New Chief Medical Officer 2
(Date:11/27/2014)... VeloReality Inc. President Gary Bauer announced the release ... world-famous velo courses for the company's VRide software and ... velo trainers. Two dozen additional Real Life Videos videos will ... -- in time for the 2014 holiday gift-giving season, ... VeloReality collection to over sixty. , The new Majorca Grand ...
(Date:11/26/2014)... Mirada, CA (PRWEB) November 26, 2014 ... the community of Perris , and it will ... Del Campo specializes in the field of Occupational Medicine ... employees. Healthpointe’s Occupational Medicine specialist delivers quality care for ... workplace safety and health. , As an ...
(Date:11/26/2014)... Boxing Day is traditionally the day ... gifts, known as a "Christmas box", from their bosses ... the coming of Boxing Day, some people may worry ... every business opportunity, and it has recently announced its ... promotion for its global customers. Then people can buy ...
(Date:11/26/2014)... (HealthDay News) -- Deaf teens have stronger language and reading ... age, a new study suggests. Researchers looked at a ... permanent hearing loss through an infant screening program conducted in ... 8 found that those who were screened by the time ... skills than deaf children who weren,t screened as infants. ...
(Date:11/26/2014)... (HealthDay News) -- Even after they,re cleared to play ... than normal, which suggests they may not be fully ... sustain a concussion may be symptom-free and cleared by ... the residual effects of concussion on the complex motor ... said principal investigator Dr. Jeffrey Bazarian, an associate professor ...
Breaking Medicine News(10 mins):Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 2Health News:Winter 2015 Weather Forecast Is Warm and Dry For VeloReality Riders With New RLV Offering 3Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 2Health News:Healthpointe now offering Occupational Medicine in their Perris Medical Clinic 3Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Spotting Hearing Problems in Infancy May Boost Reading Skills in Deaf Teens 2Health News:Harm From Baseball Concussions May Linger, Study Finds 2
... People with bipolar,disorder and depression can find hope ... Health Care Decision Support system, available,through the Web site ... resources to support health decisions including:, -- ... depression;, -- links to online and ...
... Federal ... Regulation, ... the availability of DRA Tool(TM), a new feature of its,Sentinel RCM(TM) ... editing module that comprehensively supports the,additional reporting requirements of Section 6002 ...
... will showcase an,experimental model of a walking assist device ... with weakened leg muscles, at the,International Trade Fair on ... Disabled (BARRIER FREE 2008) which will be held at ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080422/LATU095A ), Designed for people ...
... but nursing home study says risk greatest week after meds ... home patients who take antipsychotic drugs are 60 percent more ... who don,t take the drugs, a new study shows. , ... start taking the medications and gradually decreases, say Dutch researchers. ...
... surgeries has declined, so has death rate, study ... that perform fewer cardiac bypass operations don,t have more ... greater number of bypasses, a new study says. , ... hospitals that do more cardiac bypass operations have better ...
... for,Innovative Technology (CIT) today announced that CIT GAP ... Regeneration, LLC (STR), a medical,device company based in ... regeneration. CIT will invest $100,000., Joseph W. ... and counsel will help us begin developing the ...
Cached Medicine News:Health News:HAP Offers Web-Based Support for Depression and Bipolar Disorder 2Health News:HAP Offers Web-Based Support for Depression and Bipolar Disorder 3Health News:Sentry Data Systems Announces Deficit Reduction Act Compliance Tool 2Health News:Honda to Showcase Experimental Walking Assist Device 2Health News:Antipsychotic Drugs Linked to Pneumonia in Elderly 2Health News:Quality Care, Not Number of Procedures, Determines Bypass Results 2Health News:Quality Care, Not Number of Procedures, Determines Bypass Results 3Health News:CIT GAP Funds Invests in STR, LLC 2
... Finnpipette BioControl multichannel has ... as the single channel ... fits all seven multichannel ... tip cone modules. Both ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... The Research pro Electronic Pipette is ideal ... laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, ... dispensing, reverse pipetting and diluting make this ... simple functions of a manual pipette without ...
... Ergonomic Design for Unparalleled Comfort ... it. Notice the balance. Notice the trigger and ... left-handed. Thats because our pipettors are ergonomically designed ... long hours of pipetting. Productivity In The ...
Medicine Products: